ZFAS1 and colorectal carcinoma: In the validation cohort of 119 CRC patients (characterized as Validation cohort in Table 1) we observed that 111 (93%) cases displayed at least two-times higher expression of ZFAS1 in CRC tissues in comparison to paired normal colorectal tissue (Figure 1B, P < 0.0001).